U.S. Personalized Medicine Market Size & Outlook
U.S. personalized medicine market, 2018-2030 (US$M)
Related Markets
U.S. personalized medicine market highlights
- The U.S. personalized medicine market generated a revenue of USD 156,999.7 million in 2023 and is expected to reach USD 248,802.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
- In terms of segment, personalized nutrition & wellness was the largest revenue generating product in 2023.
- PM Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Personalized medicine market data book summary
| Market revenue in 2023 | USD 156,999.7 million |
| Market revenue in 2030 | USD 248,802.4 million |
| Growth rate | 6.8% (CAGR from 2023 to 2030) |
| Largest segment | Personalized nutrition & wellness |
| Fastest growing segment | PM Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, U.S. accounted for 29.7% of the global personalized medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. personalized medicine market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 92,659.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Personalized Medicine Market Scope
Personalized Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. personalized medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 31.83% in 2023. Horizon Databook has segmented the U.S. personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of key players such as GE Healthcare; Illumina, Inc.; ASURAGEN, Inc.; Danaher; Abbott Laboratories, and 23andMe, Inc. is positively influencing the market growth. Key companies are increasingly entering into partnerships, collaborations, and agreements to enhance access to personalized medicine.
The increased access to personalized cancer treatment in the U.S. due to strategic initiatives by key companies boosts market growth. For instance, in July 2023, Illumina, Inc. partnered with Pillar Biosciences, Inc. to improve access to personalized cancer treatment.
Reasons to subscribe to U.S. personalized medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. personalized medicine market databook
-
Our clientele includes a mix of personalized medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. personalized medicine market , including forecasts for subscribers. This country databook contains high-level insights into U.S. personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. personalized medicine market size, by product, 2018-2030 (US$M)
U.S. Personalized Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
